GlycoMimetics (GLYC) Short Interest Ratio & Short Volume → Top 5 Tech Stocks to Buy for 2024 (From Daily Market Alerts) (Ad) Free GLYC Stock Alerts $0.26 0.00 (-1.11%) (As of 06/7/2024 08:52 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends GlycoMimetics Short Interest DataCurrent Short Interest2,340,000 sharesPrevious Short Interest6,090,000 sharesChange Vs. Previous Month-61.58%Dollar Volume Sold Short$631,800.00Short Interest Ratio1.5 Days to CoverLast Record DateMay 15, 2024Outstanding Shares64,460,000 sharesPercentage of Shares Shorted3.63%Today's Trading Volume577,500 sharesAverage Trading Volume1,135,230 sharesToday's Volume Vs. Average51% Short Selling GlycoMimetics ? Sign up to receive the latest short interest report for GlycoMimetics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartGLYC Short Interest Over TimeGLYC Days to Cover Over TimeGLYC Percentage of Float Shorted Over Time Ad Daily Market AlertsTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world's most powerful tech companies (including Microsoft, Intel, and Google) investing billions. And one tiny company will be the driving force behind this new tech revolution…Click below for your free report "Top 5 Tech Stocks to Buy in 2024", GlycoMimetics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/20242,340,000 shares $631,800.00 -61.6%N/A1.5 $0.27 4/30/20246,090,000 shares $10.96 million +102.3%N/A4.6 $1.80 4/15/20243,010,000 shares $6.79 million +89.3%N/A6.6 $2.26 3/31/20241,590,000 shares $4.77 million +6.7%N/A4.3 $3.00 3/15/20241,490,000 shares $3.81 million -4.5%N/A4.2 $2.56 2/29/20241,560,000 shares $4.51 million +9.1%N/A4.6 $2.89 Get the Latest News and Ratings for GLYC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for GlycoMimetics and its competitors with MarketBeat's FREE daily newsletter. 2/15/20241,430,000 shares $4.42 million +43.3%N/A4.5 $3.09 1/31/2024997,900 shares $2.99 million +24.8%N/A3.5 $3.00 1/15/2024799,700 shares $2.49 million +40.3%N/A3.3 $3.11 12/31/2023570,000 shares $1.35 million -11.2%N/A2.9 $2.36 12/15/2023641,600 shares $1.27 million -23.7%N/A3.8 $1.98 11/30/2023841,200 shares $1.38 million -4.3%N/A7 $1.64 11/15/2023878,900 shares $1.22 million -1.6%N/A7.5 $1.39 10/31/2023893,500 shares $1.12 million -8.9%N/A7.3 $1.25 10/15/2023981,100 shares $1.39 million +4.3%N/A8.1 $1.42 9/30/2023940,300 shares $1.41 million -7.8%N/A8.2 $1.50 9/15/20231,020,000 shares $1.44 million -1.9%N/A8.8 $1.41 8/31/20231,040,000 shares $1.66 million -6.3%N/A7.6 $1.60 8/15/20231,110,000 shares $1.78 million -4.3%N/A6.6 $1.60 7/31/20231,160,000 shares $1.90 million -4.9%N/A5.1 $1.64 7/15/20231,220,000 shares $2.01 million -1.6%N/A5.2 $1.65 6/30/20231,240,000 shares $2.16 million +1.6%N/A5.1 $1.74 6/15/20231,220,000 shares $2.33 million -14.1%N/A4.3 $1.91 5/31/20231,420,000 shares $2.64 million +7.6%N/A4.5 $1.86 5/15/20231,320,000 shares $2.75 million -2.2%N/A2.8 $2.08 4/30/20231,350,000 shares $1.89 million -13.5%N/A1.3 $1.40 4/15/20231,560,000 shares $2.29 million -23.5%N/A1.2 $1.47 3/31/20232,040,000 shares $2.57 million -0.5%N/A1.5 $1.26 3/15/20232,050,000 shares $3.05 million -23.5%4.5%1.4 $1.49 2/28/20232,680,000 shares $4.13 million +92.8%5.8%1.8 $1.54 2/15/20231,390,000 shares $2.11 million +40.0%3.0%1 $1.52 1/31/2023992,600 shares $2.89 million +50.2%2.2%1 $2.91 1/15/2023660,700 shares $2.00 million +7.8%1.6%1 $3.02 12/30/2022613,000 shares $1.86 million +20.8%1.5%1.1 $3.03 12/15/2022507,300 shares $1.03 million -0.6%1.2%1.2 $2.04 11/30/2022510,200 shares $1.10 million -14.2%1.2%1.4 $2.16 11/15/2022594,500 shares $1.01 million +3.6%1.4%1.9 $1.70 10/31/2022574,100 shares $389,412.03 +19.7%1.4%5.1 $0.68 10/15/2022479,700 shares $298,133.55 +2.4%1.1%3.9 $0.62 9/30/2022468,700 shares $258,581.79 -5.8%1.1%3.6 $0.55Top 5 AI Stocks to Buy for 2024 (Ad)The electric vehicle boom is accelerating – and fast.Click to View The 5 Best AI Stocks to Invest In 9/15/2022497,300 shares $341,098.07 -1.8%1.2%3.7 $0.69 8/31/2022506,300 shares $384,788.00 +6.1%1.2%3.5 $0.76 8/15/2022477,300 shares $400,932.00 -10.9%1.1%3.5 $0.84 7/31/2022535,500 shares $355,036.50 -6.8%1.6%3.6 $0.66 7/15/2022574,500 shares $363,141.45 +4.3%1.7%3.4 $0.63 6/30/2022551,000 shares $329,442.90 -17.1%1.7%3.1 $0.60 6/15/2022664,400 shares $372,794.84 +2.3%2.0%3.7 $0.56 5/31/2022649,500 shares $432,437.10 +5.8%1.5%3.7 $0.67 5/15/2022613,700 shares $346,126.80 -2.3%1.5%3.1 $0.56 4/30/2022628,300 shares $451,496.38 +3.9%1.5%3 $0.72 4/15/2022605,000 shares $605,000.00 -1.1%1.4%3 $1.00 3/31/2022612,000 shares $697,680.00 -2.3%1.5%2.9 $1.14 3/15/2022626,400 shares $645,192.00 -8.9%1.5%2.6 $1.03 2/28/2022687,600 shares $845,748.00 +1.3%1.7%2.6 $1.23 2/15/2022678,600 shares $719,316.00 -10.1%1.6%2.4 $1.06 1/31/2022754,700 shares $898,093.00 +13.5%1.8%2.4 $1.19 1/15/2022665,200 shares $824,848.00 +1.2%N/A2 $1.24 12/31/2021657,600 shares $946,944.00 -2.7%1.6%1.9 $1.44 12/15/2021676,000 shares $1.03 million +1.8%1.6%1.1 $1.52 11/30/2021664,300 shares $1.12 million -10.2%1.6%1 $1.69 11/15/2021739,400 shares $1.58 million -0.5%1.8%1.1 $2.14 10/29/2021743,300 shares $1.42 million -12.7%1.8%1.2 $1.91 10/15/2021851,000 shares $1.68 million -21.9%2.1%1.3 $1.98 9/30/20211,090,000 shares $2.39 million +1.9%2.6%1.7 $2.19 9/15/20211,070,000 shares $2.29 million -2.7%2.6%2.1 $2.14 8/31/20211,100,000 shares $2.44 million -28.6%2.7%2.4 $2.22 8/13/20211,540,000 shares $3.05 million -6.7%3.7%3.2 $1.98 7/30/20211,650,000 shares $3.33 million No Change4.0%2.4 $2.02 7/15/20211,650,000 shares $3.35 million +7.1%4.0%2.3 $2.03 6/30/20211,540,000 shares $3.57 million -37.1%3.7%1.9 $2.32 6/15/20212,450,000 shares $6.32 million -11.6%5.9%3.2 $2.58 5/28/20212,770,000 shares $7.06 million +26.5%6.7%3.5 $2.55 5/14/20212,190,000 shares $5.52 million -11.0%5.3%2.4 $2.52 4/30/20212,460,000 shares $6.15 million +74.5%6.0%3 $2.50 4/15/20211,410,000 shares $3.71 million +6.8%3.4%1.6 $2.63 3/31/20211,320,000 shares $3.83 million +3.9%3.2%1.5 $2.90 3/15/20211,270,000 shares $4.20 million +18.7%3.2%1.5 $3.31 2/26/20211,070,000 shares $3.66 million +16.4%2.7%1.3 $3.42 2/12/2021919,100 shares $3.74 million +4.6%2.5%1.2 $4.07 1/29/2021878,800 shares $3.22 million -2.9%2.3%1.2 $3.66 1/15/2021904,700 shares $3.40 million -54.3%2.4%1.3 $3.76 12/31/20201,980,000 shares $7.50 million -21.7%5.3%3.2 $3.79 12/15/20202,530,000 shares $9.21 million +36.0%6.7%4.3 $3.64 11/30/20201,860,000 shares $6.81 million -5.6%4.9%3.7 $3.66 11/15/20201,970,000 shares $6.88 million +1.0%5.2%4.7 $3.49 10/30/20201,950,000 shares $5.62 million -11.4%5.2%5.6 $2.88 10/15/20202,200,000 shares $7.55 million +8.9%5.8%7.4 $3.43 9/30/20202,020,000 shares $6.20 million -5.6%5.4%5.2 $3.07 9/15/20202,140,000 shares $7.62 million -0.5%5.7%4.2 $3.56 8/31/20202,150,000 shares $7.93 million -2.7%5.7%2.8 $3.69Top 5 AI Stocks to Buy for 2024 (Ad)The electric vehicle boom is accelerating – and fast.Click to View The 5 Best AI Stocks to Invest In 8/14/20202,210,000 shares $8.18 million -3.5%6.0%2.8 $3.70 7/31/20202,290,000 shares $9.02 million -7.7%6.2%2.9 $3.94 7/15/20202,480,000 shares $9.94 million -11.1%7.4%3.3 $4.01 6/30/20202,790,000 shares $10.49 million +4.5%8.3%4.1 $3.76 6/15/20202,670,000 shares $8.09 million -0.4%8.0%4.8 $3.03 5/29/20202,680,000 shares $7.58 million -0.7%8.0%8 $2.83 5/15/20202,700,000 shares $8.40 million -3.2%8.1%8.5 $3.11 4/30/20202,790,000 shares $7.78 million -3.1%8.3%9.9 $2.79 4/15/20202,880,000 shares $7.43 million -6.8%8.6%11.2 $2.58 3/31/20203,090,000 shares $7.73 million -4.6%9.2%12.1 $2.50 3/13/20203,240,300 shares $8.62 million +0.9%9.7%15.9 $2.66 2/28/20203,210,000 shares $6.90 million +0.6%9.6%15.4 $2.15 2/14/20203,190,000 shares $9.89 million -4.8%9.6%14.4 $3.10 1/31/20203,350,000 shares $12.26 million +3.1%10.1%13.9 $3.66 1/15/20203,250,000 shares $14.17 million -1.5%9.8%13.1 $4.36 12/31/20193,300,000 shares $15.05 million +0.9%9.9%13.3 $4.56 GLYC Short Interest - Frequently Asked Questions What is GlycoMimetics' current short interest? Short interest is the volume of GlycoMimetics shares that have been sold short but have not yet been closed out or covered. As of May 15th, investors have sold 2,340,000 shares of GLYC short. Learn More on GlycoMimetics' current short interest. What is a good short interest ratio for GlycoMimetics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. GLYC shares currently have a short interest ratio of 2.0. Learn More on GlycoMimetics's short interest ratio. Which institutional investors are shorting GlycoMimetics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of GlycoMimetics: Ikarian Capital LLC, Affinity Asset Advisors LLC, and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is GlycoMimetics' short interest increasing or decreasing? GlycoMimetics saw a decrease in short interest in the month of May. As of May 15th, there was short interest totaling 2,340,000 shares, a decrease of 61.6% from the previous total of 6,090,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does GlycoMimetics' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to GlycoMimetics: Rallybio Co. (8.08%), Aileron Therapeutics, Inc. (1.26%), Eledon Pharmaceuticals, Inc. (0.77%), BioXcel Therapeutics, Inc. (4.34%), Checkpoint Therapeutics, Inc. (12.68%), MediciNova, Inc. (0.34%), Affimed (1.77%), Lantern Pharma Inc. (5.50%), Leap Therapeutics, Inc. (5.29%), CalciMedica, Inc. (0.59%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short GlycoMimetics stock? Short selling GLYC is an investing strategy that aims to generate trading profit from GlycoMimetics as its price is falling. GLYC shares are trading down $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against GlycoMimetics? A short squeeze for GlycoMimetics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of GLYC, which in turn drives the price of the stock up even further. How often is GlycoMimetics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GLYC, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Rallybio Short Interest Aileron Therapeutics Short Interest Eledon Pharmaceuticals Short Interest BioXcel Therapeutics Short Interest Checkpoint Therapeutics Short Interest MediciNova Short Interest Affimed Short Interest Lantern Pharma Short Interest Leap Therapeutics Short Interest CalciMedica Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:GLYC) was last updated on 6/10/2024 by MarketBeat.com Staff From Our PartnersIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promi...Smallcaps Daily | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredRSVP: Charles Payne’s Cash Flow WorkshopDid you know you could "cash flow" the stocks in your portfolio? Without selling a single share of stock? ...Unstoppable Prosperity | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GlycoMimetics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share GlycoMimetics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.